Literature DB >> 10691008

A successful pregnancy in a heterozygote for OTC deficiency treated with sodium phenylbutyrate.

I Redonnet-Vernhet1, F Rouanet, J M Pedespan, C Hocke, F Parrot.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10691008     DOI： 10.1212/wnl.54.4.1008

Source DB:  PubMed          Journal:  Neurology        ISSN： 0028-3878            Impact factor:   9.910


× No keyword cloud information.
  5 in total

1.  Pregnancy issues in inherited metabolic disorders.

Authors:  Philip J Lee
Journal:  J Inherit Metab Dis       Date:  2006 Apr-Jun       Impact factor: 4.982

2.  Effect of Ornithine Transcarbamylase (OTC) Deficiency on Pregnancy and Puerperium.

Authors:  Rastislav Sysák; Katarína Brennerová; Romana Krlín; Peter Štencl; Igor Rusňák; Mária Vargová
Journal:  Diagnostics (Basel)       Date:  2022-02-05

3.  Multidisciplinary management of ornithine transcarbamylase (OTC) deficiency in pregnancy: essential to prevent hyperammonemic complications.

Authors:  Stephanie Lamb; Christina Yi Ling Aye; Elaine Murphy; Lucy Mackillop
Journal:  BMJ Case Rep       Date:  2013-01-02

Review 4.  Clinical and experimental applications of sodium phenylbutyrate.

Authors:  Tommaso Iannitti; Beniamino Palmieri
Journal:  Drugs R D       Date:  2011-09-01

Review 5.  Impact of pregnancy on inborn errors of metabolism.

Authors:  Gisela Wilcox
Journal:  Rev Endocr Metab Disord       Date:  2018-03       Impact factor: 6.514
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.